Your browser doesn't support javascript.
loading
Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.
de Foy, K A; Gayther, S A; Colledge, W H; Crockett, S; Scott, I V; Evans, M J; Ponder, B A.
Affiliation
  • de Foy KA; CRC Human Cancer Genetics Research Group, Addenbrooke's Hospital, Cambridge, UK.
Br J Cancer ; 77(10): 1642-4, 1998 May.
Article in En | MEDLINE | ID: mdl-9635841
ABSTRACT
Female transgenic mice lacking a functional c-mos proto-oncogene develop ovarian teratomas, indicating that c-mos may behave as a tumour-suppressor gene for this type of tumour. We have analysed the entire coding region of the c-MOS gene in a series of human ovarian teratomas to determine whether there are any cancer-causing alterations. DNA from twenty teratomas was analysed by single-strand conformational analysis (SSCA) and heteroduplex analysis (HA) to screen for somatic and germline mutations. In nine of these tumours the entire gene was also sequenced. A previously reported polymorphism and a single new sequence variant were identified, neither of which we would predict to be disease-causing alterations. These results suggest that mutations in the coding region of the c-MOS gene do not play a significant role in the genesis of human ovarian teratomas.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Teratoma / Genes, mos Limits: Female / Humans Language: En Journal: Br J Cancer Year: 1998 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Teratoma / Genes, mos Limits: Female / Humans Language: En Journal: Br J Cancer Year: 1998 Document type: Article Affiliation country: United kingdom